How Does iTind Work?
Mechanism of Action
Information, service support or product demonstration required?
iTind is a temporarily implanted nitinol device. The minimally invasive treatment with iTind aims to deliver rapid and effective relief from BPH symptoms.
iTind is inserted in an efficient and straightforward procedure with a short learning curve. Through gentle pressure on the tissue and localized ischemia, the iTind aims to reshape the tissue of the prostatic urethra and the bladder neck, creating new channels through which urine can flow.
Patients are able to return home during the 5-7 day treatment. After the implantation period of 5-7 days, the device is completely removed.
The iTind is placed into the prostatic urethra in a narrow, folded configuration.
During the implantation period of 5-7 days, the device expands and exerts gentle pressure at three precise points to remodel the prostatic urethra and the opening to the bladder.
After 5-7 days the device is completely removed, leaving a wider opening through which urine can flow, and relieving the symptoms of BPH for years to come.
Scientific Publications 1
Clinical data demonstrate that the first generation TIND boasts a durability of three years, and powerful efficacy at 36 months is also demonstrated by the second-generation and commercially available iTind.